These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16047465)

  • 21. Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe.
    Schwab P; Louder A; Li Y; Mallick R; Bays H
    Drugs Aging; 2014 Sep; 31(9):683-94. PubMed ID: 25091271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colesevelam: a review of its use in hypercholesterolemia.
    Robinson DM; Keating GM
    Am J Cardiovasc Drugs; 2007; 7(6):453-65. PubMed ID: 18076213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance.
    Rivers SM; Kane MP; Busch RS; Bakst G; Hamilton RA
    Endocr Pract; 2007; 13(1):11-6. PubMed ID: 17360295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.
    Dayer-Berenson L; Finckenor M
    Postgrad Med; 2014 May; 126(3):126-34. PubMed ID: 24918798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
    Marrs JC
    Drugs Aging; 2012 May; 29(5):e1-e12. PubMed ID: 22530704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
    Gavin JR; Jones MR; Ford DM; Truitt KE
    Drugs Aging; 2014 Jun; 31(6):461-70. PubMed ID: 24777691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
    Corsini A; Windler E; Farnier M
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of colesevelam HCl in type 2 diabetes mellitus therapy.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):19-24. PubMed ID: 19494474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia.
    Esan O; Viljoen A; Wierzbicki AS
    Expert Opin Pharmacother; 2022 Aug; 23(12):1363-1370. PubMed ID: 35968655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia.
    Stein EA; Marais AD; Szamosi T; Raal FJ; Schurr D; Urbina EM; Hopkins PN; Karki S; Xu J; Misir S; Melino M
    J Pediatr; 2010 Feb; 156(2):231-6.e1-3. PubMed ID: 19879596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of soy protein on lipoprotein lipids and fecal bile acid excretion in men and women with moderate hypercholesterolemia.
    Maki KC; Butteiger DN; Rains TM; Lawless A; Reeves MS; Schasteen C; Krul ES
    J Clin Lipidol; 2010; 4(6):531-42. PubMed ID: 21122701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome.
    Camilleri M; Acosta A; Busciglio I; Boldingh A; Dyer RB; Zinsmeister AR; Lueke A; Gray A; Donato LJ
    Aliment Pharmacol Ther; 2015 Mar; 41(5):438-48. PubMed ID: 25594801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.
    Staels B
    Postgrad Med; 2009 May; 121(3 Suppl 1):25-30. PubMed ID: 19494475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.
    Goldfine AB; Fonseca VA
    Postgrad Med; 2009 May; 121(3 Suppl 1):13-8. PubMed ID: 19494473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent.
    Davidson MH; Dicklin MR; Maki KC; Kleinpell RM
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2663-71. PubMed ID: 11060828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):5-6. PubMed ID: 19494471
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.
    Wedlake L; Thomas K; Lalji A; Anagnostopoulos C; Andreyev HJ
    Clin Ther; 2009 Nov; 31(11):2549-58. PubMed ID: 20109999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colesevelam hydrochloride.
    Steinmetz KL
    Am J Health Syst Pharm; 2002 May; 59(10):932-9. PubMed ID: 12040732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colesevelam HCl and ezetimibe combination therapy provides effective lipid-lowering in difficult-to-treat patients with hypercholesterolemia.
    Zema MJ
    Am J Ther; 2005; 12(4):306-10. PubMed ID: 16041193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of cholesterol and bile acid metabolism, and early atherogenesis in hamsters fed GT16-239, a novel bile acid sequestrant (BAS).
    Wilson TA; Nicolosi RJ; Rogers EJ; Sacchiero R; Goldberg DJ
    Atherosclerosis; 1998 Oct; 140(2):315-24. PubMed ID: 9862274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.